Submitted by Anonymous (not verified) on 24 October 2023 - 8:11
Human medicines European public assessment report (EPAR): Heplisav B, hepatitis B surface antigen, Hepatitis B, Date of authorisation: 18/02/2021, Revision: 5, Status: Authorised
Source: